Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE

Parschauer Karah Herdman received 28,895 Ultragenyx Pharmaceutical Inc. shares as an award (Form 4)

Traded Apr 16, 2026 · Filed Apr 20, 2026

On Apr 16, 2026, Parschauer Karah Herdman (EVP and Chief Legal Officer) received 28,895 Ultragenyx Pharmaceutical Inc. shares as an award, leaving 95,715 shares. Filed Apr 20, 2026 (Form 4).

Awarded
28,895 shares
Holding after
95,715 shares
Trading plan
No
Role
EVP and Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockAward28,89595,715Direct

Source

View original at SEC

Related